Friday, July 10, 2026

Drug profile · INN

etonogestrel + ethinylestradiol

etonogestrel + ethinylestradiol (NUVARING) is an FDA-listed pharmaceutical active ingredient. Associated with Organon Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — etonogestrel + ethinylestradiol

Quick answer

etonogestrel + ethinylestradiol (NUVARING) is an FDA-listed pharmaceutical active ingredient. Associated with Organon Pharma Pty Ltd.

Key facts

INN etonogestrel + ethinylestradiol
Brand NUVARING

Approval history

Authority Status Date
TGA approved

Frequently asked questions

What is etonogestrel + ethinylestradiol?

etonogestrel + ethinylestradiol (NUVARING) is an FDA-listed pharmaceutical active ingredient. Associated with Organon Pharma Pty Ltd.

What is the brand name for etonogestrel + ethinylestradiol?

NUVARING is a marketed brand name for etonogestrel + ethinylestradiol. Check FDA Drugs@FDA for the current US label holder and prescribing information.